Xiao Tang Kong, M.

Professor Xiao Tang Kong, M.D., is an associate clinical professor of Neurology at the University of California-Irvine, where she is dedicated to innovative teaching methods in the field of neuro-oncology. As a board-certified UCI Health neuro-oncologist, Dr. Kong specializes in the diagnosis and treatment of primary brain tumors, metastatic cancers affecting the brain and spinal cord, and the neurological complications arising from tumors or cancer therapies. Dr. Kong's academic journey began at the Keck School of Medicine at the University of Southern California, where she earned her medical degree. She further honed her expertise through rigorous internships, residencies, and fellowships at the UC Irvine Medical Center and the David Geffen School of Medicine at UCLA. Her comprehensive training has equipped her with the skills necessary to address complex neurological conditions with precision and care. In her clinical practice, Dr. Kong is deeply involved in managing clinical trials for brain and spinal cord tumors. Her commitment to advancing medical research is evident in her efforts to bring safe and effective clinical trials to her patients, ensuring they have access to the latest therapeutic options. Her research interests include brain tumors, rare brain tumors, metastatic cancers, glioblastoma, and CNS lymphoma. Dr. Kong is passionate about bridging the gap between cutting-edge research and patient care. She actively collaborates with multidisciplinary teams to develop personalized treatment plans that cater to the unique needs of each patient. Her dedication to patient-centered care and her contributions to the field of neuro-oncology have made her a respected figure in the medical community. Beyond her clinical and research endeavors, Dr. Kong is committed to mentoring the next generation of healthcare professionals. She is actively involved in teaching and training medical students, residents, and fellows, sharing her knowledge and experience to inspire future leaders in neurology and oncology.